Growth in Spokane Jubilant HollisterStier is expanding its Spokane Valley facility with new production lines and approximately 250 employees by 2026, signaling increased capacity for sterile fill-finish manufacturing and potential cross-sell of additional contract manufacturing services to biotech and pharma partners.

Allergy & Sterile Focus As a leader in allergenic extracts and a national contract manufacturer of sterile injectable vials and lyophilized products, there is a strong opportunity to target allergy, respiratory, and sterile fill-finish clients needing compliant, scalable manufacturing, testing, and packaging support.

Quality & Compliance Recent FDA-related quality lapses and mold investigation delays highlight a need for enhanced quality systems, faster issue resolution, and robust quality-by-design partnerships, presenting a chance to offer remediation support, audits, and continuous improvement services.

Strategic Partnerships Past collaborations with local education institutions and expansion of production capabilities indicate openness to joint ventures and supply-chain partnerships; proactively engage for workforce training programs, co-funding opportunities, and shared manufacturing innovations.

Financial & Scale With a revenue range of 100–250 million and a multi-site growth trajectory, there is appetite for value-added services such as equipment modernization, data analytics, cloud-based manufacturing platforms, and regulatory readiness solutions to optimize margins and throughput.